Literature DB >> 26491002

Bilateral BRVO in a patient with recurrent prostate cancer.

Veronica Castro-Navarro1, Stephen G Odaibo2, Devon H Ghodasra2, Cagri G Besirli2.   

Abstract

Bilateral cases of branch retinal vein occlusions (BRVO) are infrequent and often related to systemic disease. A 72-year-old man with biochemical recurrence of prostate cancer was referred for decreased vision in his left eye. Fundus examination and fluorescein angiography disclosed bilateral BRVO with patches of peripheral non-perfusion and macular oedema in the left eye. A systemic work up revealed elevated fibrinogen and reduced free protein S antigen, consistent with an underlying hypercoagulable state. Cancer is a well-known cause of hypercoagulability. We report the first case of bilateral BRVO related to biochemical recurrence of prostate cancer and a proven coagulation derangement. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2015        PMID： 26491002      PMCID： PMC4620206          DOI： 10.1136/bcr-2015-212463

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  16 in total

Review 1.  Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.

Authors:  Mirian C H Janssen; Martin den Heijer; Johannes R M Cruysberg; Hub Wollersheim; Sebastian J H Bredie
Journal:  Thromb Haemost       Date:  2005-06       Impact factor: 5.249

2.  Leuprolide acetate and central retinal vein occlusion.

Authors:  Thomas J Federici
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 Nov-Dec

3.  Incidental 'early' diagnosis of colorectal carcinoma by way of central retinal vein occlusion.

Authors:  A Ozkaya; H M Ozkaya; Z Alkın; A Demirok
Journal:  J Fr Ophtalmol       Date:  2014-03-20       Impact factor: 0.818

4.  The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.

Authors:  Matus Rehak; Vera Krcova; Ludek Slavik; Evzen Fric; Katerina Langova; Jana Ulehlova; Jiri Rehak
Journal:  Can J Ophthalmol       Date:  2010-04       Impact factor: 1.882

5.  [Central retinal vein occlusion as the first symptom of ovarian cancer].

Authors:  V M Asensio-Sánchez; M C Hernaez-Ortega; I Castresana-Jauregui
Journal:  Arch Soc Esp Oftalmol       Date:  2012-07-25

Review 6.  Hypercoagulability syndromes.

Authors:  R H Thomas
Journal:  Arch Intern Med       Date:  2001-11-12

Review 7.  Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.

Authors:  Adil Jaulim; Badia Ahmed; Tina Khanam; Irini P Chatziralli
Journal:  Retina       Date:  2013-05       Impact factor: 4.256

8.  The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Scot E Moss; Stacy M Meuer; Barbara E K Klein
Journal:  Arch Ophthalmol       Date:  2008-04

9.  Thrombophilia and retinal vascular occlusion.

Authors:  Charles J Glueck; Robert K Hutchins; Joel Jurantee; Zia Khan; Ping Wang
Journal:  Clin Ophthalmol       Date:  2012-08-28

Review 10.  Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data.

Authors:  Petr Kolar
Journal:  J Ophthalmol       Date:  2014-06-09       Impact factor: 1.909
View more
  2 in total

1.  Bilateral Type 1 Idiopathic Macular Telangiectasia in a Female Patient: Multimodal Imaging of a Rare Presentation.

Authors:  Mohamad Reza Niyousha; Narges Hassanpoor; Sasan Jafari
Journal:  Case Rep Ophthalmol       Date:  2021-05-10

2.  Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study.

Authors:  Anette Tarp Hansen; Katalin Veres; Paolo Prandoni; Kasper Adelborg; Henrik Toft Sørensen
Journal:  Cancer Med       Date:  2018-09-27       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.